Long-Chain Fatty Acid Oxidation Disorders In-Clinic Disease Monitoring Program

Running, not enrolling

Conditions studied: Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)

In brief

The primary objective of this study is to assess the long-term safety, including pregnancy, infant, and lactation outcomes, of patients with LC-FAOD who are enrolled in the DMP.

Key facts

Study ID
NCT04632953
Run by
Ultragenyx Pharmaceutical Inc
People needed
150
Starts
2021-11-30
Expected to finish
2035-12-01
Last updated by the study team
2026-06-03

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.